Join us for the SATURN3 International Conference 2027
– Registration and Abstract Submission opening soon –
We are delighted to invite you to the SATURN3 International Conference, taking place on June 22–23, 2027, in Heidelberg, Germany.
The conference will bring together leading international scientists and clinicians for two days of cutting-edge science, inspiring presentations, scientific exchange, and networking.
When & Where:
Tuesday, June 22 & Wednesday, June 23, 2027
German Cancer Research Center (DKFZ)
Communication Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
What to Expect:
The SATURN3 research consortium – Spatial And Temporal Resolution of Intratumoral Heterogeneity in 3 hard-to-treat CaNcers – is funded by the German Federal Ministry of Research, Technology and Space as part of the National Decade Against Cancer.
Over the course of two days, latest insights into pancreatic, breast, and colorectal cancer, as well as computational biology will be presented.
The conference will showcase the highlights and key findings of this five-year collaborative research programme and explore new perspectives in cancer research.
In addition we have invited international leaders in the field, who will provide inspiring perspectives on current developments and future directions in cancer research.
Conference Highlights:
- Cutting-edge scientific programme featuring SATURN3 researchers and international speakers
- Poster sessions – present and discuss your research
- Meet-the-Speakers Lunch – informal opportunity for direct exchange with leading experts
- Get-Together Evening Event – networking and scientific exchange
- Industry Exhibition & Satellite Symposia on “Diagnostic and Therapeutic Innovations”
Present your research. Exchange ideas. Connect with leading experts in cancer research.
Join us on June 22–23, 2027, and be part of the SATURN3 International Conference – celebrating five years of collaborative research and looking ahead to the future of cancer research.
We look forward to welcoming you to Heidelberg!
Plenary Speakers
- Andrew Aguirre
Dana-Farber Cancer Institute/Harvard, Boston, USA - Eduard Batlle
Institute for Research in Biomedicine, Barcelona, Spain - Isidro Cortés-Ciriano
University of Oxford, Oxford, England - Christina Curtis
Stanford University School of Medicine, Stanford, USA - Scott Lowe
Memorial Sloan Kettering Cancer Center, New York, USA - Ilaria Malanchi
The Francis Crick Institute, London, England - Grainne O’Kane
St Vincent’s University Hospital, Dublin, Ireland - Sabine Tejpar
UZ Leuven, Leuven, Belgium - Nick Turner
The Institute of Cancer Research, London, England - Peter Van Loo
MD Anderson Cancer Center, Houston, USA
PDAC Session:
Scott Lowe
Memorial Sloan Kettering Cancer Center, New York, USA
Andrew Aguirre
Dana-Farber Cancer Institute/Harvard, Boston, USA
Grainne O´Kane
St Vincent’s University Hospital, Dublin, Ireland
Breast Cancer Session:
Ilaria Malanchi
The Francis Crick Institute, London, England
Nick Turner
The Institute of Cancer Research, London, England
tbd
Colon Cancer Session:
Eduard Batlle
Institute for Research in Biomedicine, Barcelona, Spain
Sabine Tejpar
UZ Leuven, Leuven, Belgium
tbd
Computational Session:
Christina Curtis
Stanford University School of Medicine, Stanford, USA
Isidro Cortés-Ciriano
University of Oxford, Oxford, England
Peter Van Loo
MD Anderson Cancer Center, Houston, USA
Imprint
Organizer:
Stiftung Universitätsmedizin Essen and German Cancer Research Center (DKFZ)
Event contact:
Dr. Vivien Ullrich, University Hospital Essen
E-Mail: vivien.ullrich@uk-essen.de
